LivaNova PLC
LIVN55.000USD
-0.910-1.63%
終値 09/19, 16:00（ET）15分遅れの株価
3.00B時価総額
損失額直近12ヶ月PER
詳細情報 LivaNova PLC 企業名
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.
企業情報
企業コードLIVN
会社名LivaNova PLC
上場日Oct 19, 2015
最高経営責任者「CEO」Mr. Vladimir A. Makatsaria
従業員数2900
証券種類Ordinary Share
決算期末Oct 19
本社所在地20 Eastbourne Terrace
都市LONDON
証券取引所NASDAQ Global Select Consolidated
国United Kingdom
郵便番号W2 6LG
電話番号442033250662
ウェブサイトhttps://www.livanova.com/
企業コードLIVN
上場日Oct 19, 2015
最高経営責任者「CEO」Mr. Vladimir A. Makatsaria
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
+15.05%
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
26.68K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
12.75K
--
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
+19.06%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
+49.63%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
-14.25%
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
8.52K
+4.49%
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
6.48K
+86.48%
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
5.67K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
1.94K
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
+15.05%
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
26.68K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
12.75K
--
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
+19.06%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
+49.63%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
-14.25%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
データなし
地域別USD
会社名
収益
比率
United States
169.16M
53.39%
Rest of World
87.99M
27.77%
Europe
59.70M
18.84%
事業別
地域別
データなし
株主
更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
11.67%
PRIMECAP Management Company
8.50%
The Vanguard Group, Inc.
4.47%
Millennium Management LLC
4.44%
State Street Global Advisors (US)
3.81%
他の
67.10%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
11.67%
PRIMECAP Management Company
8.50%
The Vanguard Group, Inc.
4.47%
Millennium Management LLC
4.44%
State Street Global Advisors (US)
3.81%
他の
67.10%
種類
株主統計
比率
Investment Advisor
47.32%
Investment Advisor/Hedge Fund
34.23%
Hedge Fund
15.48%
Research Firm
3.07%
Pension Fund
2.18%
Bank and Trust
1.36%
Individual Investor
0.38%
Sovereign Wealth Fund
0.12%
Insurance Company
0.04%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
564
56.85M
104.11%
-6.95M
2025Q1
581
56.61M
103.82%
-8.04M
2024Q4
586
56.98M
104.84%
-8.56M
2024Q3
563
55.15M
101.56%
-9.48M
2024Q2
546
57.21M
105.64%
-8.52M
2024Q1
547
58.00M
107.51%
-6.90M
2023Q4
532
56.62M
105.11%
-7.28M
2023Q3
527
56.14M
104.20%
-8.51M
2023Q2
529
55.56M
103.33%
-9.55M
2023Q1
544
57.05M
106.52%
-4.67M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
6.53M
11.97%
-36.05K
-0.55%
Mar 31, 2025
PRIMECAP Management Company
4.61M
8.45%
-145.65K
-3.06%
Mar 31, 2025
The Vanguard Group, Inc.
2.65M
4.87%
+316.99K
+13.56%
Mar 31, 2025
Millennium Management LLC
2.07M
3.79%
-983.66K
-32.27%
Mar 31, 2025
State Street Global Advisors (US)
2.10M
3.85%
-950.00
-0.05%
Mar 31, 2025
AQR Capital Management, LLC
1.57M
2.88%
+829.12K
+111.71%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.33M
2.44%
+20.96K
+1.60%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.41M
2.59%
+73.94K
+5.53%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
